Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-110595

SVP, Chief Medical Officer gave up 9,032 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Attar Eyal C. SVP, Chief Medical Officer 2021-08-25 Shares withheld for taxes −9,032 $3.98 $35,947 98,968 D
Loading xslF345X03/tm2126037-1_4seq1.xml…